| __timestamp | Arrowhead Pharmaceuticals, Inc. | Verona Pharma plc |
|---|---|---|
| Wednesday, January 1, 2014 | 24419536 | 1802274 |
| Thursday, January 1, 2015 | 34718089 | 2512761 |
| Friday, January 1, 2016 | 40998209 | 2894488 |
| Sunday, January 1, 2017 | 32022880 | 8096274 |
| Monday, January 1, 2018 | 19110051 | 7985229 |
| Tuesday, January 1, 2019 | 26556257 | 8994597 |
| Wednesday, January 1, 2020 | 52275890 | 29772000 |
| Friday, January 1, 2021 | 80981000 | 33907000 |
| Saturday, January 1, 2022 | 124431000 | 26579000 |
| Sunday, January 1, 2023 | 90932000 | 49868547 |
| Monday, January 1, 2024 | 98761000 |
Unveiling the hidden dimensions of data
In the competitive world of biopharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for operational efficiency. Over the past decade, Arrowhead Pharmaceuticals, Inc. and Verona Pharma plc have demonstrated contrasting trends in their SG&A expenditures. From 2014 to 2023, Arrowhead's SG&A expenses surged by over 300%, peaking in 2022. This reflects their aggressive expansion and investment in administrative capabilities. In contrast, Verona Pharma's SG&A expenses, while increasing, have shown a more moderate growth of approximately 170% over the same period, with a notable spike in 2023. This suggests a strategic scaling of operations. Interestingly, data for 2024 is incomplete for Verona Pharma, indicating potential shifts in their financial strategy. These trends highlight the dynamic nature of financial management in the biopharma sector, where strategic spending can significantly impact a company's market position.
Selling, General, and Administrative Costs: argenx SE vs Verona Pharma plc
Selling, General, and Administrative Costs: BeiGene, Ltd. vs Arrowhead Pharmaceuticals, Inc.
Selling, General, and Administrative Costs: Incyte Corporation vs Verona Pharma plc
Viatris Inc. or Arrowhead Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: Jazz Pharmaceuticals plc vs Verona Pharma plc
Cost Management Insights: SG&A Expenses for Grifols, S.A. and Arrowhead Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Corcept Therapeutics Incorporated vs Arrowhead Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of TG Therapeutics, Inc. and Verona Pharma plc
Who Optimizes SG&A Costs Better? Verona Pharma plc or Amneal Pharmaceuticals, Inc.
Comparing SG&A Expenses: Verona Pharma plc vs Veracyte, Inc. Trends and Insights
Operational Costs Compared: SG&A Analysis of HUTCHMED (China) Limited and Arrowhead Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Arrowhead Pharmaceuticals, Inc. and MannKind Corporation